Α-Acetyldigoxin
Appearance
This article needs additional citations for verification. (August 2007) |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Bioavailability | 90%(Oral) |
Protein binding | 20-30% |
Elimination half-life | 40h |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.024.414 |
Chemical and physical data | |
Formula | C43H66O15 |
Molar mass | 822.975 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Acetyldigoxin is a cardiac glycoside. It is an acetyl derivative of digoxin. Its positive cardioinotropic effect starts after 3-4h and maximizes after 6-8h. It is prescribed for congestive chronic cardiac failure class II, III and IV.